Technical Analysis for APLS - Apellis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
A 61.21 -1.43% -0.89
APLS closed down 1.43 percent on Wednesday, March 22, 2023, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Bollinger Band Squeeze Range Contraction -1.43%
NR7 Range Contraction -1.43%
Hammer Candlestick Bullish -2.92%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 12 hours ago
Lower Bollinger Band Support about 12 hours ago
Fell Below Lower Bollinger Band about 14 hours ago
Fell Below Previous Day's Low about 14 hours ago
Down 2 % about 14 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Apellis Pharmaceuticals, Inc. Description

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The Company is developing APL-2 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) by subcutaneous injection, which is an injection into the tissue under the skin. It is developing APL-2 for the treatment of geographic atrophy (GA) and intermediate age-related macular degeneration (AMD) by intravitreal injection, which is an injection into the eye. The Company is developing APL-1 for the treatment of chronic obstructive pulmonary disease (COPD) by inhaled administration.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Organ Systems Eye Inflammatory Diseases Macular Degeneration Pulmonary Disease Chronic Obstructive Pulmonary Disease Hemoglobin Autoimmune And Inflammatory Disease Complement System Acquired Hemolytic Anemia Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria Copd Intravitreal Administration

Is APLS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 70.755
52 Week Low 33.345
Average Volume 1,705,617
200-Day Moving Average 55.17
50-Day Moving Average 57.61
20-Day Moving Average 64.21
10-Day Moving Average 63.35
Average True Range 2.82
RSI 48.98
ADX 26.39
+DI 18.97
-DI 19.40
Chandelier Exit (Long, 3 ATRs) 62.30
Chandelier Exit (Short, 3 ATRs) 65.86
Upper Bollinger Bands 67.15
Lower Bollinger Band 61.27
Percent B (%b) -0.01
BandWidth 9.17
MACD Line 1.38
MACD Signal Line 2.10
MACD Histogram -0.7279
Fundamentals Value
Market Cap 4.63 Billion
Num Shares 75.6 Million
EPS -3.32
Price-to-Earnings (P/E) Ratio -18.43
Price-to-Sales 4846.49
Price-to-Book 33.50
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 63.90
Resistance 3 (R3) 63.96 63.12 63.45
Resistance 2 (R2) 63.12 62.44 63.09 63.30
Resistance 1 (R1) 62.17 62.02 61.75 62.11 63.15
Pivot Point 61.33 61.33 61.13 61.30 61.33
Support 1 (S1) 60.38 60.65 59.96 60.32 59.27
Support 2 (S2) 59.54 60.23 59.51 59.12
Support 3 (S3) 58.59 59.54 58.97
Support 4 (S4) 58.53